Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Fatima S Hussain und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Miami, Miami, FL, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Patient Acceptance of Health Care, Ethnicity, Healthcare Disparities. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Khan Family Fund, Arena of Care Grant.
Abstract (Originalsprache)
Background and Aims Biases in healthcare pose challenges for inflammatory bowel disease (IBD) patients from underrepresented races and ethnicities. Our study aimed to assess the quality of and access to care among underrepresented racial and ethnic populations using a diverse database.
Methods
We used the OneFlorida Data Trust, representing over half of Florida’s population. We performed a retrospective study from 2012 to 2020. Advanced IBD therapies included a prescription of at least 1 biologic agent or tofacitinib. Disease activity markers included C-reactive protein (CRP), hemoglobin (Hgb), albumin, and white blood cell (WBC). Regression analyses compared the rates of medication use, healthcare utilization, and disease severity by race and ethnicity. Geographic distribution of advanced IBD therapy was analyzed at the county level.
Results
Our study included 10 578 patients. Hispanic patients utilized more biologics than non-Hispanic White (NHW) patients (odds ratio [OR]: 1.3, P < .0001). Non-Hispanic Black patients utilized more steroids than NHW (OR: 1.2, P = .0004). Hispanics had fewer visits to emergency departments (EDs) and fewer admissions compared with NHW (OR: 0.7 and 0.6, respectively; P < .0001). Non-Hispanic Black patients visited ED more frequently than NHW patients (OR: 1.3, P < .0001). Hispanics had lower disease activity markers than NHW based on CRP (OR: 0.5, P = .005), Hgb (OR: 0.4, P < .0001), albumin (OR: 0.7, P < .0001), and WBC (OR: 0.5, P < .0001). Geographic distribution of advanced IBD therapy showed clustered areas in southern and northern Florida.
Conclusions
Our data show an improved access to care pattern in Hispanic patients. However, disparities still exist, and this is evident in the healthcare utilization trends observed among non-Hispanic Black patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Miami, Miami, FL, USA.
- College of Medicine, University of Florida, Gainesville, FL, USA.
- Department of Health Outcomes & Biomedical Informatics, University of Florida, Gainesville, FL, USA.
- Department of Pediatrics, University of Florida, Gainesville, FL, USA.
- Department of Medicine, University of Florida, Gainesville, FL, USA.
- Department of Medicine, University of Miami, Miami, FL, USA.
ORCID-Profile: Fatima S Hussain
Förderung
- Khan Family Fund
- Arena of Care Grant
Zitieren
APA
Hussain, F. S., Potlach, T., Chi, X., Gurka, M. J., Hall, J., Setya, A., Chaudhry, N. A., Pham, A., Damas, O. M., Kerman, D., Abreu, M. T., & Zimmermann, E. M. (2025). Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae219
Vancouver
Hussain FS, Potlach T, Chi X, Gurka MJ, Hall J, Setya A, et al. Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae219
BibTeX
@article{Hussain2025,
author = {Hussain, Fatima S and Potlach, Tomas and Chi, Xiaofei and Gurka, Matthew J and Hall, Jaclyn and Setya, Aniruddh and Chaudhry, Naueen A and Pham, Angela and Damas, Oriana M and Kerman, David and Abreu, Maria T and Zimmermann, Ellen M},
title = {Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae219}
}
EUVIMED